Evidence map›Paper›PMID 37121981›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer.

Luca Giovanella, Lisa Milan, Wolfgang Roll, Manuel Weber, Simone Schenke, Michael Kreissl, Alexis Vrachimis, Kim Pabst, Tuncel Murat, Petra Petranovic Ovcaricek and 4 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Redefining standard of care in thyroid cancer: Lessons from the IoN trial.European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Five-year follow-up of Estimabl 2 trail: a critical appraisal.European journal of nuclear medicine and molecular imaging · 2025
    Article
  5. European journal of nuclear medicine and molecular imaging · 2025
    Article
  6. External validation of a predictive model for post-treatment persistent disease byEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Luca GiovanellaClinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Ospedale San Giovanni, Via A. Gallino 6, 6500, Bellinzona, CH, Switzerland. luca.giovanella@eoc.ch.ORCID http://orcid.org/0000-0003-0230-0974
Lisa MilanClinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Ospedale San Giovanni, Via A. Gallino 6, 6500, Bellinzona, CH, Switzerland.
Wolfgang RollClinic for Nuclear Medicine, University Hospital Münster, Münster, Germany.
Manuel WeberClinic for Nuclear Medicine, University Hospital Essen, Essen, Germany.
Simone SchenkeClinic for Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany.
Michael KreisslClinic for Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany.
Alexis VrachimisDepartment of Nuclear Medicine, German Oncology Center, Limassol, Cyprus.
Kim PabstClinic for Nuclear Medicine, University Hospital Essen, Essen, Germany.
Tuncel MuratDepartment of Nuclear Medicine, Hacettepe University, Ankara, Turkey.
Petra Petranovic OvcaricekDepartment of Oncology and Nuclear Medicine, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia.
Burkhard RiemannClinic for Nuclear Medicine, University Hospital Münster, Münster, Germany.
Luca CerianiClinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Ospedale San Giovanni, Via A. Gallino 6, 6500, Bellinzona, CH, Switzerland.
Alfredo CampenniNuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy.
Rainer GörgesClinic for Nuclear Medicine, University Hospital Essen, Essen, Germany.
Ente Ospedaliero Cantonale · CHEssen University Hospital · DEUniversity Hospital Magdeburg · DEUniversity Hospital Münster · DEHacettepe University · TRLimassol General Hospital · CYUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAn accurate postoperative assessment is pivotal to inform postoperative

methodsAge, sex, histology, T stage, N stage, risk classes, remnant estimation, TSH, and Tg were identified as potential predictors and were put into regression algorithm (conditional inference tree, ctree) to develop a risk stratification model for predicting the presence of metastases in PT-WBS.

resultsThe lymph node (N) stage identified a partition of the population into two subgroups (N-positive vs N-negative). Among N-positive patients, a Tg value  > 23.3 ng/mL conferred a 83% probability to have metastatic disease compared to those with lower Tg values. Additionally, N-negative patients were further substratified in three subgroups with different risk rates according to their Tg values. The model remained stable and reproducible in the iterative process of cross validation.

conclusionsWe developed a simple and robust decision tree model able to provide reliable informations on the probability of persistent/metastatic DTC after surgery. These information may guide post-surgery

Indexed as

AdenocarcinomaThyroid NeoplasmsDecision TreesHumansIodine RadioisotopesThyroglobulinIodine-131Iodine RadioisotopesThyroglobulinDecision tree modelDifferentiated thyroid cancerDTCPost-treatment whole-body scintigraphyPT-WBSTgThyroglobulin

Identifiers

PMID37121981
PMCPMC10317893
OpenAlexW4367602005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.